InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2026-09-03 16:34:44 ET · period of report 2026-09-02 · accession 0001225208-26-007620 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-09-03 16:34 2026-09-02 BSX O'Connor Padraig Andrew EVP, Gbl Ops M - OptEx $0.00 +1,171 8,459 +16% $0
D 2026-09-03 16:34 2026-09-02 BSX O'Connor Padraig Andrew EVP, Gbl Ops F - Tax $48.37 -567 7,892 -7% -$27.4K
D 2026-09-03 16:34 2026-09-02 BSX O'Connor Padraig Andrew EVP, Gbl Ops M - OptEx $0.00 -1,171 3,516 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-02 M A 1,171 $0.00 8,459 D — — (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F2) Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
2 Common Common Stock 2026-09-02 F D 567 $48.37 7,892 D — —
3 Derivative Restricted Stock Units 2026-09-02 M D 1,171 $0.00 3,516 D — · — to 2029-09-02 1,171 Common Stock (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F3) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant. (F3) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.